Clinical trial
Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational…
NCT00065130 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT00065130 |
|---|---|
| Title | Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational Diabetes |
| Official title | Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Basal/Bolus Therapy for Patients With Gestational Diabetes |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes, Gestational Diabetes |
| Intervention type | Drug |
| Interventions | human insulin, insulin NPH, insulin aspart |
| Enrollment | 27 |
| Start date | Apr 1, 2000 |
| Primary completion | Dec 1, 2003 |
| Completion | Dec 1, 2003 |
| First posted | Jul 18, 2003 |
| Last update posted | Dec 22, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: